Skip to main content
Log in

Absorption of theophylline from a new theophylline controlled-release capsule

  • Letter To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hirtz J (1984) The absorption window: Fact or fiction? Pharm Intern 5: 175–178

    Google Scholar 

  2. Staib AH, Loew D, Harder S, Graul EH, Pfab R (1986) Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device. Eur J Clin Pharmacol 30: 691–697

    Google Scholar 

  3. Bryson JC, Dukes GE, Kirby MG, Heizer WD, Powell JR (1989) Effect of altering small bowel transit time on sustained release theophylline absorption. J Clin Pharmacol 29: 733–738

    Google Scholar 

  4. Wagner JG (1975) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, Illinois

    Google Scholar 

  5. Davis SS, Khosla R, Wilson CG, Washington N, Leslie ST, Malkowska S (1990) The gastrointestinal transit of a controlled release formulation of indomethacin. Int J Pharm 60: 191–196

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kehe, C., Wick, K., McCarville, S. et al. Absorption of theophylline from a new theophylline controlled-release capsule. Eur J Clin Pharmacol 40, 319–320 (1991). https://doi.org/10.1007/BF00315219

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315219

Key words

Navigation